Literature DB >> 301968

Treatment of post-myocardial infarction angina by intra-aortic ballon pumping and emergency revascularization.

J Bardet, M Rigaud, J C Kahn, J F Huret, I Gandjbakhch, J P Bourdarias.   

Abstract

Twenty-one patients with postinfarction angina (2 to 15 days after acute myocardial infarction) unresponsive to medical therapy were treated by intra-aortic balloon pumping (IABP). Anginal pain and electrocardiographic (ECG) ST-segment changes were prevented in all patients. Coronary angiograms were obtained during IABP without complication and confirmed severe coronary artery disease. Of the four nonoperated patients, three had reinfarction and two died of cardiogenic shock. Seventeen patients underwent aorta-coronary bypass grafting, associated with aneurysmectomy in two patients and closure of a ventricular septal defect in one. Sixteen patients survived the operation. All survivors are in clinically improved condition and 14 are pain free from 9 to 28 months postoperatively, but three have mild heart failure.

Entities:  

Mesh:

Year:  1977        PMID: 301968

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Percutaneous intraaortic balloon pumping: initial experience.

Authors:  M Gonzalez; E Installé; J Trémouroux
Journal:  Intensive Care Med       Date:  1982       Impact factor: 17.440

2.  Mechanical circulatory assistance by intra-aortic balloon pumping for the treatment of cardiogenic shock.

Authors:  J P Bourdarias; R Gourgon; J Bardet
Journal:  Intensive Care Med       Date:  1978-01       Impact factor: 17.440

3.  The efficacy of medical stabilization prior to myocardial revascularization in early refractory postinfarction angina.

Authors:  A J Roberts; J H Sanders; J H Moran; S M Spies; M L Lesch; L L Michaelis
Journal:  Ann Surg       Date:  1983-01       Impact factor: 12.969

4.  Intra-aortic balloon pump (ΙΑΒΡ): from the old trends and studies to the current "extended" indications of its use.

Authors:  Haralabos Parissis; Alan Soo; Bassel Al-Alao
Journal:  J Cardiothorac Surg       Date:  2012-12-11       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.